Bambusa Therapeutics Inc.

Three IPOs, one direct listing, and two SPACs priced during a challenging week for growth stocks. Just one SPAC is currently scheduled to list in the week ahead, although some smaller deals may also join the calendar throughout the week. Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring.